摘要
目的评价中图糖尿病患者对甘精胰岛素(来得时)SoloStar预填充胰岛素注射笔的满意度和使川情况。方法在中国成年糖尿病患者中进行为期3个月的观察性、多中心、前瞻性登记研究。患者以前使用过胰岛素或未使用过胰岛素,由医师决定给予来得时SoloStar治疗.基线时收集患者对以前所用注射笔的评价。使用SoloStar注射笔3个月后,评价患者对SoloStar注射笔的满意度和使用情7兑,并收集医师对SoloStar的评价。结果共1052例患者纳入分析,平均年龄56.5岁(27.6%≥65岁),平均糖尿病病程7.6年,男性54.6%,2型糖尿病占94.1%,伴视力受损6.5%.伴手灵活性受损2.4%,其中488例(46.4%)患者以前使用过胰岛素注射笔。患者使用SoloStar注射笔3个月后,感到满意或非常满意的比例高达95.3%。绝大多数患者打算继续使用SoloStar注射笔(94.7%)并愿意推荐给其他患者(86.0%)。、与以前使用的注射笔比较,多数患者认为操作SoloStar注射笔更容易(57.3%)和更方便(60.7%)。此外,共63份医师调查表纳人分析,超过70%的医师对SoloStar注射笔各项特性的评价均为好或很好,96.8%的医师认为培训SoloStar更容易和更快。结论绝大多数患者对SoloStar注射笔感到满意或非常满意,多数医师也认为好或很好,这提示SoloStar注射笔在患者和医师中的接受度良好。
Objective To evaluate the satisfaction and usability of SoloStar, a prefilled pen for injecting insulin glargine ( Lantus@, Sanofi ) in Chinese diabetic patients. Methods This was a 3-month, observational, multicenter, prospective registry study in adult diabetic patients who were ever insulin users or insulin naive. The SuloStar was prescrihed at physician's discretion. At baseline, patients were asked to evaluate their previous insulin pen if applicable. After 3-month SoloStar use, the satisfaction and usability in using SoloStar were assessed, and the evaluation from physicians was also collected. Results Total 1 052 patients aged 56.5 years (27.6% ≥65 years) , with mean diabetes duration 7.6 years, 54.6% male, 94.1% type 2 diabetes, 6.5% visual impairment, and 2.4% dexterity impairment, were analyzed. Of these, 488 patients (46.4%) had previously used insulin pen. Most patients (95.3%) rated SoloStar as " satisfied/very satisfied". Most patients planned to continue using SoloStar (94.7%) and would recommend it to others(86.0% ). Compared with previous insulin pen, most patients felt using SoloStar became easier ( 57.3 % ) and mm'e convenient ( 60.7 % ). 63 physician questionnaires were analyzed, over 70% physicians rated SuloStar features as good/excellent, and 96.8% physicians regarded training un SoloStar as easier and quicker than other pens. Conculsion Most patients were satisfied/very satisfied with SoloStar and most physicians rated SuloStar as good/excellent, suggesting that SoloStarwas well accepted by patients and physicians
出处
《中华内分泌代谢杂志》
CAS
CSCD
北大核心
2012年第9期715-719,共5页
Chinese Journal of Endocrinology and Metabolism
关键词
胰岛素注射笔
糖尿病
满意度
Insulin pen Diabetes mellitus Satisfaction